Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

Journal of cutaneous pathology·2026

Same author

Spatially-resolved single-cell imaging of melanoma brain metastases identifies localized immune patterns predictive of immune checkpoint blockade response.

Neuro-oncology·2026

Same author

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

The EMBO journal·2026

Same author

In vivo single-cell ribosome profiling reveals cell-type-specific translational programs during aging.

Molecular cell·2026

Same author

Evaluating T-cell clonality in skin using a quantitative TRBC1 clonality score.

The Journal of investigative dermatology·2026

Same author

Population-level migration modeling of North America's birds through data integration with BirdFlow.

Movement ecology·2026

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Noncutaneous Melanomas: A Single-Center Analysis.

Valerio Del Prete¹, Karla Chaloupka, David Holzmann

¹Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.

Dermatology (Basel, Switzerland)

|December 1, 2015

Summary

This summary is machine-generated.

Noncutaneous melanomas have unique metastatic patterns and few mutations. Immunotherapy shows promise, with vulvovaginal melanoma responding well to imatinib and ipilimumab.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Experiment Videos

Last Updated: Mar 29, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Area of Science:

Oncology
Dermatology
Medical Genetics

Background:

Optimal treatment strategies for noncutaneous melanomas remain undetermined.
This study investigates key characteristics of noncutaneous melanomas to inform treatment algorithms.

Purpose of the Study:

To compare systemic treatment-relevant mutational status in noncutaneous melanoma.
To analyze metastatic patterns and treatment responses in noncutaneous melanoma patients.

Main Methods:

Retrospective single-center study.
Analysis of 64 noncutaneous melanoma patients treated from January 2006 to September 2013.

Main Results:

c-KIT mutations were specific to vulvovaginal melanoma (4/7).
Low rates of NRAS (1/7) and BRAF (0/21) mutations were observed.
Metastatic patterns varied: vulvovaginal/sinonasal melanomas primarily spread to lymph nodes, while ocular melanomas metastasized to the liver.
Imatinib (3/3) and ipilimumab (3/10) showed disease control in vulvovaginal melanomas; sorafenib yielded poor results and adverse reactions.

Conclusions:

Noncutaneous melanomas exhibit limited tumor-signaling pathway mutations and distinct metastatic behaviors.
Immunotherapy demonstrates comparable response rates in mucosal melanoma to those seen in cutaneous melanoma.